ask="48.15"
ask_size="200"
average_daily_volume="367832"
bid="40.00"
bid_size="100"
book_value="0.00"
change="-2.66"
change_from_200_day_moving_average="-4.06"
change_from_50_day_moving_average="-0.71"
change_from_52_week_high="-15.11"
change_From_52_week_low="15.52"
change_in_percent="-5.48%"
close="45.87"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.44"
ebitda="-97.57M"
eps_estimate_current_year="-4.07"
eps_estimate_next_quarter="-1.13"
eps_estimate_next_year="-1.87"
ex_dividend_date="N/A"
float_shares="24414000"
high="48.14"
high_52_weeks="60.98"
last_trade_date="2/28/2017"
last_trade_price="45.87"
last_trade_size="30792"
last_trade_time="4:00pm"
low="45.83"
low_52_weeks="30.35"
market_capitalization="1.26B"
moving_average_200_day="49.93"
moving_average_50_day="46.58"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.50"
open="48.14"
pe_ratio="N/A"
peg_ratio="0.20"
percent_change_from_200_day_moving_average="-8.14%"
percent_change_from_50_day_moving_average="-1.53%"
percent_change_from_52_week_high="-24.78%"
percent_change_from_52_week_low="+51.14%"
previous_close="48.53"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="43.38"
revenue="30.69M"
shares_outstanding="27436000"
short_ratio="6.80"
stock_exchange="NMS"
symbol="FPRX"
volume="488188"
weeks_range_52="30.35 - 60.98"
